T. Rowe Price Health Care ETF

TMED

Börsenwert 31,7 Mio. $

Sector ETFs have long been a part of the overall ETF ecosystem. The ETF's transparency, flexibility, and tax efficiency have made it a vehicle for all sorts of sector strategies.

Healthcare stocks have boosted the ETF space in recent weeks. Despite some potential headwinds, the sector and its related thematic ETFs, like active healthcare ETF TMED, have performed.

The T. Rowe Price Health Care ETF (TMED) led all T. Rowe Price funds last week, posting a 3.4% return.

In an uncertain marketplace, where are investors to go? Sector funds could provide one intriguing set of tools to consider.

Active ETFs continue to rise in significance for investors, with flows on track for another record amid more and more launches. Amid that rise for the category, certain ETFs have stood out of late, the T.

Healthcare innovation and biotechnology are standing out right now as areas with a lot of promise for investors. September's rate cut has brightened prospects, while R&D, boosted by AI, is driving new drug discoveries.

Earnings season is in full swing and investors are watching closely. For many of those investors, earnings season can be the trigger to make small shifts or even big wholesale changes in portfolios.

In a world where passive investing tends to dominate the headlines, T. Rowe Price is gambling on an alternative formula: sector-focused active management, and at lower costs.

Active manager T. Rowe Price announced the expansion of its equity ETF offerings with three new sector strategies.

BALTIMORE, June 12, 2025 /PRNewswire/ -- T. Rowe Price (NASDAQ-GS: TROW), a global investment management firm, announced today the addition of three new active transparent equity exchange-traded funds (ETF): T. Rowe Price Financials ETF (Ticker: TFNS), T. Rowe Price Health Care ETF (Ticker: TMED), and T. Rowe Price Natural Resources ETF (Ticker: TURF). The new funds began trading on NASDAQ today. T. Rowe Price's active ETF roster now sits at 22 offerings.